News resources

Today's most mentioned stocks
Incyte Corp (INCY)2 stories...
American International Group Inc (AIG)2 stories...
LM Ericsson Telephone ADR Reptg 1 Ord Shs Class B (ERIC)2 stories...
New York Times Co (NYT)1 story...
Ford Motor Co (F)1 story...
Topics in the news
Earnings Reports
Movers
Market Reports
Economic Indicators
Mergers and Acquisitions
advertisement

Bristol-Myers Squibb Co: All Recent News

Final Glance: Pharmaceuticals companies 11/24/2009
NEW YORK (AP) - Shares of some top pharmaceuticals companies were mixed at the close of trading:... Associated Press
4 Platform Drugmakers to Invest In 11/24/2009
No special shoes required. At Motley Fool
Early Glance: Pharmaceuticals companies 11/24/2009
NEW YORK (AP) - Shares of some top pharmaceuticals companies are mixed at 10 a.m.:... Associated Press
Bristol-Myers, Origin Lead High-Flying Stocks 11/24/2009
Origin Agritech, Rockwell Collins, Xcel Energy, Accenture and Bristol-Myers Squibb hit 52-week highs. At TheStreet.com
Zacks Analyst Blog Highlights: Pozen, Sanofi-Aventis,... 11/23/2009
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Business Wire
($) Remember, Remember the Strength of November 11/23/2009
Being this up going into year-end puts pressure on funds to avoid selling. At TheStreet.com
Healthcare Stocks: Safe and Speculative 11/23/2009
NEW YORK (TheStreet) -- Allos Therapeutics is the best speculative bet in the sector. Watch this video for the safest and biggest growth stock to add to your portfolio. At TheStreet.com
Bristol-Myers extends partnership with Asterand 11/23/2009
NEW YORK (AP) - Drugmaker Bristol-Myers Squibb Co. and Asterand PLC are extending a research collaboration for up to three years, Asterand said Monday. Associated Press
Rocket Stocks for the Week 11/23/2009
These stocks could surge higher in the coming week. At TheStreet.com
($) Sanofi Has Lots of Upside Catalysts 11/23/2009
Looks like the patent worries aren't so dire after all. At TheStreet.com
$ Review 11/21/2009
... At Barron's
FDA OKs Abilify for autism-linked irritability 11/20/2009
PRINCETON, N.J. (AP) - The U.S. Food and Drug Administration has approved top-selling Abilify as a treatment for autism-related irritability in children from the ages of 6 to 17, drug maker Bristol-Myers Squibb Co. said Friday. Associated Press
U.S. Food and Drug Administration Approves ABILIFY®... 11/20/2009
Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA)... Business Wire
Exxon Mobil, Bristol-Myers Squibb: Money Flow Leaders (XOM, BMY) 11/20/2009
... At Wall Street Journal
$ Bristol-Myers Faces Lower Sales 11/20/2009
... At Barron's
More recent US:BMY headlines...
More News
Market Report
News by Symbol
Today's Investing Articles
Breaking News
News by Topic
News by Industry
MSNBC News
MSN Money
Search MSN Money
Message Boards
Site Status